scNeuroResilience Uncovering cell-type-specific neurodegeneration resilience mechanisms
- Coordinator
- Medizinische Universitat Innsbruck, Austria
- Runs
- 1 February 2027 to 31 January 2032
- Status
- Running
- EU funding
- €1.5m
- Total cost
- €1.5m
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101300706
What the project is doing
In the project's own words, from its summary on CORDIS.
Neurodegenerative diseases (NDs) are an immense burden to patients, their families and society. For decades, they have been defined by two core characteristics. First, different NDs are characterized by the deposition of different toxic proteins in the nervous system, which are critical drivers of disease. Secondly, in different NDs different neuron subtypes are preferentially lost. Uncovering causal mechanisms explaining this selective neuronal vulnerability in NDs has remained difficult due to technical limitations.
Here, I will comprehensively model this experimentally to establish the missing link and uncover the molecular mechanisms of how ND-causing toxic proteins cause selective neuronal vulnerability, and how resilient neurons survive. I will use an innovative Drosophila-human cross-species approach that I developed. As a discovery tool, we will perform parallelized single-cell RNA sequencing (scRNA-seq) of hundreds of different mature Drosophila neuron types that are exposed to defined amounts of toxic proteins.
Based on the differential responses we will be able to build a holistic atlas of neuron-type-intrinsic vulnerability and resilience mechanisms in response to ND-causing toxic proteins. These will be computationally mapped to human, experimentally assessed in patient brains, and causal mechanisms established in in vivo modifier experiments in flies. We will also assess shared resilience mechanisms, since co-pathology of multiple toxic proteins is common.
Therefore, we will employ concomitant protein detection and scRNA-seq to differentiate neuron-type-specific pathways that protect from toxic protein build-up vs. those that protect from the downstream cellular damage. Thereby, we will advance a fundamental scientific question and reverse engineer the brains‘ own resilience mechanisms for a new class of ND treatment targets.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Medizinische Universitat Innsbruck | Innsbruck | Austria | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI